3Swanson D R. Fish oil, Raynaud's syndrome,and undiscovered public knowledge[J]. Perspectives Biolog Med,1986,30(1):18-22.
4Chang B B,Di Giacomo R,Kremer J,et al. Effects of fish oil fatty acid ingestion in patients with Raynaud's syndrome[J] .Surgical Forum,1988,39(3):324-326.
5Di Giacomo R,Kremer J M,Shah D M . Fishoil dietary supple men-tation in patients with Raynaud's phenomenon: a double-blind,cont-rolled,prospective study[J]. Am J Med,1989,86(2):158-164.
6Del F G,Rocha B H,Nohama P. Design,implementation and eva-luation of a clinical decision support system to prevent adverse drug events[J]. Stud Health Technol Inform,2000,77(7): 740-744 .
7Sphiris N,Nanas S, Paraskevopoulou H,et al. A decision support soft-ware package for medical treatment of I.C.U. patients[J]. Stud Health Technol Inform,1997,43(9): 911-914 .
8Lo Bello L,Pistone G,Restuccia S,et al. 5-fluorouracil alone versus 5-fluorouracil plus folinic acid in the treatment of colorectal carcinoma: meta-analysis[J]. Int J Clin Pharmacol Ther,2000,38(12): 553-562.
9Chertow G M,Lee J,Kuperman G J,et al. Guided medication dosing for inpatients with renal insufficiency[J]. JAMA,2001,286(22): 2839-2844.
10Jonathan M,Pankaj R,Jennifer L,et al.Effects of computerized phy-sician order entry on prescribing practices[J].Arch Intern Med,2000,160(18):2741-2747.
